AU672186B2 - Peptide compounds having therapeutic activity - Google Patents

Peptide compounds having therapeutic activity

Info

Publication number
AU672186B2
AU672186B2 AU31678/93A AU3167893A AU672186B2 AU 672186 B2 AU672186 B2 AU 672186B2 AU 31678/93 A AU31678/93 A AU 31678/93A AU 3167893 A AU3167893 A AU 3167893A AU 672186 B2 AU672186 B2 AU 672186B2
Authority
AU
Australia
Prior art keywords
therapeutic activity
peptide compounds
peptide
compounds
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31678/93A
Other languages
English (en)
Other versions
AU3167893A (en
Inventor
Myles Edward Pierson
James Donald Rosamond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929220543A external-priority patent/GB9220543D0/en
Priority claimed from GB929220761A external-priority patent/GB9220761D0/en
Application filed by Astra AB filed Critical Astra AB
Publication of AU3167893A publication Critical patent/AU3167893A/en
Assigned to ASTRA AKTIEBOLAG reassignment ASTRA AKTIEBOLAG Alteration of Name(s) of Applicant(s) under S113 Assignors: FISONS CORPORATION
Application granted granted Critical
Publication of AU672186B2 publication Critical patent/AU672186B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU31678/93A 1991-12-20 1992-12-21 Peptide compounds having therapeutic activity Ceased AU672186B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US81098591A 1991-12-20 1991-12-20
US810985 1991-12-20
GB929220543A GB9220543D0 (en) 1992-09-29 1992-09-29 Pharmacologically active compounds
GB9220543 1992-09-29
GB929220761A GB9220761D0 (en) 1992-10-02 1992-10-02 Pharmaceutically active compounds
GB9220761 1992-10-02
PCT/GB1992/002369 WO1993013126A1 (en) 1991-12-20 1992-12-21 Peptide compounds having therapeutic activity

Publications (2)

Publication Number Publication Date
AU3167893A AU3167893A (en) 1993-07-28
AU672186B2 true AU672186B2 (en) 1996-09-26

Family

ID=27266393

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31678/93A Ceased AU672186B2 (en) 1991-12-20 1992-12-21 Peptide compounds having therapeutic activity

Country Status (11)

Country Link
EP (1) EP0619823A1 (show.php)
JP (1) JPH08500324A (show.php)
AU (1) AU672186B2 (show.php)
CA (1) CA2126236A1 (show.php)
FI (1) FI942898A0 (show.php)
HU (1) HU211564A9 (show.php)
IL (1) IL104161A0 (show.php)
MX (1) MX9207458A (show.php)
NO (1) NO942350L (show.php)
NZ (1) NZ246195A (show.php)
WO (1) WO1993013126A1 (show.php)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7762610B2 (ja) * 2022-03-28 2025-10-30 雪印メグミルク株式会社 アンジオテンシン変換酵素阻害ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754248R (fr) * 1969-08-01 1971-02-01 Farmaceutici Italia Polypeptides a activite
NZ218607A (en) * 1985-12-19 1989-10-27 Pennwalt Corp Tri-to acta-peptides with sulphate ester groups: obesity treatment
IL84478A0 (en) * 1986-11-18 1988-04-29 Pennwalt Corp Peptides with sulfate ester groups and their preparation
DE69017704T2 (de) * 1989-11-27 1995-07-20 Fisons Corp Hexapeptide mit sulphat-ester-gruppen.

Also Published As

Publication number Publication date
FI942898L (fi) 1994-06-17
AU3167893A (en) 1993-07-28
NZ246195A (en) 1995-11-27
IL104161A0 (en) 1993-05-13
CA2126236A1 (en) 1993-07-08
NO942350D0 (show.php) 1994-06-20
WO1993013126A1 (en) 1993-07-08
FI942898A7 (fi) 1994-06-17
FI942898A0 (fi) 1994-06-17
JPH08500324A (ja) 1996-01-16
HU211564A9 (en) 1995-12-28
MX9207458A (es) 1993-11-01
NO942350L (no) 1994-06-20
EP0619823A1 (en) 1994-10-19

Similar Documents

Publication Publication Date Title
AU6623894A (en) Therapeutic compounds
AU4715493A (en) Peptide compounds
AU3888793A (en) Novel medicament
AU4175093A (en) Bed
AU3414689A (en) Therapeutic peptides
ZA939317B (en) Medicament
AU6092794A (en) Oxime-substituted therapeutic compounds
AU2954692A (en) Medical preparations
AU4775693A (en) Peptide medicaments for treating disease
AU4014193A (en) Chair
GB9310199D0 (en) Therapeutic compounds
AU3542993A (en) Pharmaceutical compounds
AU5737494A (en) Human thrombospondin-4
AP9400637A0 (en) Therapeutic c compounds
AU4060289A (en) Therapeutic agents
AU5112193A (en) Chair
IL103373A0 (en) Therapeutically active compound
AU3187489A (en) Therapeutic agents
AU1500992A (en) Pharmaceutical compound
AU672186B2 (en) Peptide compounds having therapeutic activity
GB9117819D0 (en) Therapeutic compounds
ZA942911B (en) Therapeutic compounds
AU5165993A (en) Pp14-based therapy
AU3687693A (en) Fitted bed covering
AU1191895A (en) Il-6 therapy